To continue using this website, please tell us a
little about yourself:

I am a financial adviser

I am a discretionary fund manager / multimanager

I am a financial paraplanner

I work in financial services

I am a private investor

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here

Login

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
 
You are here: Factsheet
 

Zurich Sterling AXA Framlington Health

3 FE Trustnet

Underlying Fund

FE Crown Rating ( Underlying )

Fund Objective ( Underlying )

Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies.

Fund Manager ( Underlying )

Mark Hargraves

Domicile

Sector

Currency

Primary Asset Class

Fund Size

GBP 8.94m as at 29-May-2015

Downloads ( Underlying )

Unit Name

Zurich Sterling AXA Framlington Health S2

Inc/Acc

Accumulating 

Citicode

AFK3

Initial Charge

n/a

Unit Currency

GBX 

ISIN

GB00B1W4T101 

Annual Charge

0.85%

Mid

GBX 288.10

Change (Mid)

-1.20 (-0.41%)
03-Jul-2015

Unit LaunchDate

06-Aug-2007

Unit Name

Zurich Sterling AXA Framlington Health

Inc/Acc

Accumulating 

Citicode

SP03

Initial Charge

n/a

Unit Currency

GBX 

ISIN

GB0003251013 

Annual Charge

1.85%

Bid

GBX 48.00

Offer

GBX 50.60

Change (Offer)

-0.20 (-0.41%)
03-Jul-2015

Unit LaunchDate

04-Dec-2000

Performance Overview

Performance Charts

Cumulative Performance

  YTD 3m 6m 1y 3y 5y
Fund 10.34 -1.03 10.09 29.03 76.47 135.29
Sector 2.74 -1.84 2.79 6.27 23.30 32.59
Benchmark 11.03 -2.31 9.48 27.99 95.27 162.17

Discrete Performance (%)

  2014 2013 2012 2011 2010
Fund 24.64 30.22 10.74 4.76 14.93
Sector 5.16 10.14 6.76 -5.30 8.11
Benchmark 26.09 34.51 13.16 10.99 6.27

Asset Allocation ( Underlying )

breakdown chart
  Asset Class % of Fund
US Equities 70.01
Swiss Equities 9.84
UK Equities 5.89
Money Market 2.63
German Equities 2.59
Japanese Equities 2.49
Danish Equities 1.91
Canadian Equities 1.31
Israeli Equities 1.21
French Equities 1.02
Australian Equities 0.69
South African Equities 0.41

Regional Breakdown ( Underlying )

breakdown chart
  Region % of Fund
United States 70.01
Switzerland 9.84
United Kingdom 5.89
Cash 2.63
Germany 2.59
Japan 2.49
Denmark 1.91
Canada 1.31
Israel 1.21
France 1.02
Australia 0.69
South Africa 0.41

Sector Breakdown ( Underlying )

breakdown chart
  Sector % of Fund
Specialty Pharma & Pharma 33.74
Healthcare Services & Enabling Technology / Tools 28.03
Biotech Product 21.37
Devices 14.23
Cash 2.63
 

All prices in Pence Sterling (GBX) unless otherwise specified. Price performance figures are calculated on a bid price to bid price basis with net income (dividends) reinvested. Performance figures are shown in Sterling.